These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 38382900

  • 1. Small molecule- and peptide-drug conjugates addressing integrins: A story of targeted cancer treatment.
    Paulus J, Sewald N.
    J Pept Sci; 2024 Jul; 30(7):e3561. PubMed ID: 38382900
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Recent Advances in Targeted Cancer Therapy: Are PDCs the Next Generation of ADCs?
    Zhang B, Wang M, Sun L, Liu J, Yin L, Xia M, Zhang L, Liu X, Cheng Y.
    J Med Chem; 2024 Jul 25; 67(14):11469-11487. PubMed ID: 38980167
    [Abstract] [Full Text] [Related]

  • 6. Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors.
    Arosio D, Manzoni L, Corno C, Perego P.
    Recent Pat Anticancer Drug Discov; 2017 Jul 25; 12(2):148-168. PubMed ID: 28164756
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor Targeting with Small Molecule-Drug Conjugates (SMDCs) - Can They be Better than ADCs?
    Altmann KH.
    Chimia (Aarau); 2018 Mar 30; 72(3):154-155. PubMed ID: 29631670
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peptide Drug Conjugates and Their Role in Cancer Therapy.
    Heh E, Allen J, Ramirez F, Lovasz D, Fernandez L, Hogg T, Riva H, Holland N, Chacon J.
    Int J Mol Sci; 2023 Jan 03; 24(1):. PubMed ID: 36614268
    [Abstract] [Full Text] [Related]

  • 13. Preparation of Ligand-Targeted Drug Conjugates for Cancer Therapy and Their Evaluation In Vitro.
    Krishnan MA, Sengupta S, Chelvam V.
    Curr Protoc Chem Biol; 2018 Dec 03; 10(4):e50. PubMed ID: 30212603
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A Comparative Analysis of Fibroblast Activation Protein-Targeted Small Molecule-Drug, Antibody-Drug, and Peptide-Drug Conjugates.
    Zana A, Puig-Moreno C, Bocci M, Gilardoni E, Di Nitto C, Principi L, Ravazza D, Rotta G, Prodi E, De Luca R, Neri D, Cazzamalli S.
    Bioconjug Chem; 2023 Jul 19; 34(7):1205-1211. PubMed ID: 37399501
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibody-Drug Conjugates and Small Molecule-Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents.
    Casi G, Neri D.
    J Med Chem; 2015 Nov 25; 58(22):8751-61. PubMed ID: 26079148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.